Literature DB >> 8880068

Activation of group III metabotropic glutamate receptors is neuroprotective in cortical cultures.

V Bruno1, A Copani, L Bonanno, T Knoepfel, R Kuhn, P J Roberts, F Nicoletti.   

Abstract

(RS)-alpha-Methyl-4-phosphonophenylglycine (MPPG) and (S)-alpha-methyl-3-carboxyphenylalanine (M3CPA), two novel preferential antagonists of group III metabotropic glutamate (mGlu) receptors, antagonized the neuroprotective activity of L-2-amino-4-phosphono-butanoate (L-AP4) or L-serine-O-phosphate in mice cultured cortical cells exposed to a toxic pulse of N-methyl-D-aspartate. In contrast, MPPG did not influence the neuroprotective activity of the selective group II mGlu receptor agonist, (2S,1'R,2'R,3'R)-2-(2,3-dicarboxy-cyclopropyl) glycine (DCG-IV). These results indicate that activation of group III mGu receptors exerts neuroprotective activity against excitotoxic neuronal death. At least one of the two major group III mGlu receptor subtypes, i.e. mGlu4 receptor, is expressed by cultured cortical neurons, as shown by immunocytochemical analysis with specific polyclonal antibodies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880068     DOI: 10.1016/0014-2999(96)00358-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Selective mGluR1 antagonist EMQMCM inhibits the kainate-induced excitotoxicity in primary neuronal cultures and in the rat hippocampus.

Authors:  Maria Śmiałowska; Krystyna Gołembiowska; Małgorzata Kajta; Barbara Zięba; Anna Dziubina; Helena Domin
Journal:  Neurotox Res       Date:  2011-12-06       Impact factor: 3.911

2.  Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism.

Authors:  D M O'Leary; V Movsesyan; S Vicini; A I Faden
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 3.  Group III metabotropic glutamate receptors: pharmacology, physiology and therapeutic potential.

Authors:  Marion S Mercier; David Lodge
Journal:  Neurochem Res       Date:  2014-08-22       Impact factor: 3.996

4.  Selective activation of mGlu4 metabotropic glutamate receptors is protective against excitotoxic neuronal death.

Authors:  V Bruno; G Battaglia; I Ksiazek; H van der Putten; M V Catania; R Giuffrida; S Lukic; T Leonhardt; W Inderbitzin; F Gasparini; R Kuhn; D R Hampson; F Nicoletti; P J Flor
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

5.  Protein kinase C and A3 adenosine receptor activation inhibit presynaptic metabotropic glutamate receptor (mGluR) function and uncouple mGluRs from GTP-binding proteins.

Authors:  T A Macek; H Schaffhauser; P J Conn
Journal:  J Neurosci       Date:  1998-08-15       Impact factor: 6.167

6.  Group III mGlu receptor agonist, ACPT-I, exerts potential neuroprotective effects in vitro and in vivo.

Authors:  Helena Domin; Krystyna Gołembiowska; Danuta Jantas; Katarzyna Kamińska; Barbara Zięba; Maria Smiałowska
Journal:  Neurotox Res       Date:  2014-01-09       Impact factor: 3.911

Review 7.  Family C G-Protein-Coupled Receptors in Alzheimer's Disease and Therapeutic Implications.

Authors:  Ilaria Dal Prà; Ubaldo Armato; Anna Chiarini
Journal:  Front Pharmacol       Date:  2019-10-28       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.